79. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Samstag, 6. April 2013 (Posterbereich I) 10:00-11:30

Postervorträge

Basic Science: Micro RNAs in der kardiovaskulären Pathophysiologie

Diskussionsleiter: R. P. Brandes (Frankfurt am Main), S. Clauß (München), U. Landmesser (Zürich, CH)

(P1706) Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart

H. Sanchez Ruderisch, C. Eschen, D. Fliegner, E. Dworatzek, G. Kararigas, C. Westphal, V. Regitz-Zagrosek (Berlin)
(P1707) Expression von microRNA-29b, -133a und -146b und ischämische Postkonditionierung im Schweinemodell

T. Baars, P. Kleinbongard, A. Skyschally, L. Klein-Hitpass, R. Erbel, G. Heusch (Essen)
(P1708) Cardiac autophagy is regulated by miR-106b

C. Kuhn, L. Boeck, F. Dierck, S. Hille, I. Boomgaarden, T. Eschenhagen, N. Frey (Kiel, Hamburg)
(P1709) MicroRNA-126-containing endothelial microparticles reduce neointimaformation and vascular smooth muscle cell proliferation

S. Pröbsting, F. Jansen, X. Yang, K. Paul, G. Nickenig, N. Werner (Bonn)
(P1710) Circulating MicroRNA Signature of Diabetes-Associated Impaired Wound Healing

S. Dangwal, B. Stratmann, K. Schwarz, C. J. Scholz, J. Lorenzen, T. Thum, D. Tschöpe (Hannover, Bad Oeynhausen, Würzburg)
(P1711) MiRNAs expression on ascending aortic aneurysms: what should we look for?

I. Kanzler, K. Rolle, S. Schack, A.-H. Kiessling, A. Moritz, A. Beiras-Fernandez (Frankfurt am Main)
(P1712) Inhibition of the microRNA let-7 leads to functional improvement after myocardial infarction

T. Seeger, Q.-F. Xu, M. Muhly-Reinholz, A. Fischer, A. M. Zeiher, S. Dimmeler (Frankfurt am Main)
(P1713) Osteopontin is indispensible for Angiotensin II induced miR-21 induction and subsequent PTEN target regulation in cardiac fibrosis

J. Lorenzen, S. Batkai, T. Thum (Hannover)
(P1714) MicroRNA-582, a novel differentially regulated microRNA in dilated cardiomyopathy targets muscle LIM protein (MLP) and phosphodiesterase 4D

I. Boomgaarden, C. Kuhn, D. Frank, N. Frey (Kiel)
(P1715) Long term delivery of antimiRs is safe and improves metabolic syndromes in db/db mice

A. Fischer, S. Dimmeler, A. M. Zeiher, T. Seeger (Frankfurt am Main)
(P1716) HDL-bound circulating microRNAs in patients with coronary disease

J. Wagner, M. Riwanto, C. Besler, A. Knau, S. Fichtlscherer, T. Roexe, A. M. Zeiher, U. Landmesser, S. Dimmeler (Frankfurt am Main; Zürich, CH)
(P1717) microRNAs are novel plasma biomarkers for diagnosis and prognosis of abdominal aortic aneurysm disease 

S. Eken, E. Chernugobova, J. Hong, P. S. Tsao, A. Hamsten, P. Eriksson, L. Maegdefessel (Stockholm, SE; Stanford, US)
(P1718) Functional miRNA screening identifies miR-24 as a regulator of smooth muscle cell function

J. Fiedler, A. Holzmann, S. K. Gupta, T. Thum (Hannover)
(P1719) Array-based profiling reveals key regulatory role and plasma biomarker potential for different microRNAs in symptomatic patients with carotid stenosis

C. Österholm-Corbascio, E. Chernugobova, S. Eken, J. Hong, P. S. Tsao, A. Hamsten, P. Eriksson, L. Maegdefessel (Stockholm, SE; Stanford, US)
(P1720) Untersuchung des spezifischen, Mikrovesikel-vermitteltenTransfers von Mikro-RNAs durch Makrophagen auf vaskuläre Zellen

N. Erichsen, C. Troidl, S. Szardien, S. Voss, O. Dörr, J. Hoffmann, M. Willmer, J. M. Daniel, H. Möllmann, H. M. Nef, C. W. Hamm, D. G. Sedding (Gießen, Bad Nauheim)